Citi analyst Mark Kelley moved his price target for Rubicon Project shares to $10, assigning it a gross profit multiple that was derived from the average price paid in the acquisitions of TubeMogul and Turn. He believes M&A speculation will likely keep the stock near current levels. Rubicon closed yesterday down 1.8% at $8.75, but has rallied about 18% over the last three months.

03/15/17

RILY

03/15/17DOWNGRADETarget $7.5RILYNeutral

Rubicon Project downgraded to Neutral from Buy at B. Riley

B. Riley analyst Sameet Sinha downgraded Rubicon Project to Neutral and lowered his price target for the shares to $7.50 from $10.50 after the company's Q1 outlook missed expectations.

03/15/17

CHLM

03/15/17DOWNGRADETarget $8CHLMHold

Rubicon Project downgraded to Hold from Buy at Craig-Hallum

Craig-Hallum analyst Jason Kreyer downgraded Rubicon Project to Hold and cut his price target for the shares to $8 from $9 following the company's Q4 results. B. Riley this morning also downgraded the shares.

03/16/17

JEFF

03/16/17DOWNGRADETarget $7.25JEFFHold

Rubicon Project downgraded to Hold from Buy at Jefferies

Jefferies analyst Brian Fitzgerald downgraded Rubicon Project to Hold saying the company's "weak": Q1 guidance reflects uncertainty around its new investment initiatives. The analyst lowered his price target for the shares to $7.25 from $9.

UP AFTER EARNINGS: Cintas (CTAS), up 2.9%... Micron (MU), up 2.8%. ALSO HIGHER: Editas Medicine (EDIT), up 3.1% after it received the EMA's orphan medicinal product designation for EDIT-101... Twitter (TWTR), up 1.8% after it said it will start testing longer, 280-character tweets with a small group. DOWN AFTER EARNINGS: Nike (NKE), down 3.2%. ALSO LOWER: Kornit Digital (KRNT), down 12.2% after it cut its third quarter revenue guidance... Westlake Chemical Partners (WLKP), down 8.3% after it filed to sell 4.5M units for limited partners... Intra-Cellular (ITCI), down 7.2% after it filed to sell $150M in common stock... Ascendis Pharma (ASND), down 4.3% after it announced an offering of $125M of ADSs.